719 related articles for article (PubMed ID: 15934092)
21. Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 faces of lupus study.
Lalani S; Pope J; de Leon F; Peschken C;
J Rheumatol; 2010 Jan; 37(1):38-44. PubMed ID: 20008925
[TBL] [Abstract][Full Text] [Related]
22. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis.
Ståhl-Hallengren C; Jönsen A; Nived O; Sturfelt G
J Rheumatol; 2000 Mar; 27(3):685-91. PubMed ID: 10743809
[TBL] [Abstract][Full Text] [Related]
23. Accrual of organ damage over time in patients with systemic lupus erythematosus.
Gladman DD; Urowitz MB; Rahman P; Ibañez D; Tam LS
J Rheumatol; 2003 Sep; 30(9):1955-9. PubMed ID: 12966597
[TBL] [Abstract][Full Text] [Related]
24. Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving corticosteroids.
Lee C; Almagor O; Dunlop DD; Manzi S; Spies S; Chadha AB; Ramsey-Goldman R
Rheumatology (Oxford); 2006 Jan; 45(1):53-60. PubMed ID: 16278288
[TBL] [Abstract][Full Text] [Related]
25. Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort.
Andrade RM; Alarcón GS; Fernández M; Apte M; Vilá LM; Reveille JD;
Arthritis Rheum; 2007 Feb; 56(2):622-30. PubMed ID: 17265497
[TBL] [Abstract][Full Text] [Related]
26. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison.
Gladman DD; Goldsmith CH; Urowitz MB; Bacon P; Fortin P; Ginzler E; Gordon C; Hanly JG; Isenberg DA; Petri M; Nived O; Snaith M; Sturfelt G
J Rheumatol; 2000 Feb; 27(2):373-6. PubMed ID: 10685799
[TBL] [Abstract][Full Text] [Related]
27. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.
Ruiz-Irastorza G; Egurbide MV; Ugalde J; Aguirre C
Arch Intern Med; 2004 Jan; 164(1):77-82. PubMed ID: 14718326
[TBL] [Abstract][Full Text] [Related]
28. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity.
Neville C; Clarke AE; Joseph L; Belisle P; Ferland D; Fortin PR
J Rheumatol; 2000 Mar; 27(3):675-9. PubMed ID: 10743807
[TBL] [Abstract][Full Text] [Related]
29. Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus.
Wang M; Gladman DD; Ibañez D; Urowitz MB
Arthritis Care Res (Hoboken); 2012 Jun; 64(6):833-7. PubMed ID: 22290935
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus--a 5-yr prospective study.
Stoll T; Sutcliffe N; Mach J; Klaghofer R; Isenberg DA
Rheumatology (Oxford); 2004 Aug; 43(8):1039-44. PubMed ID: 15161983
[TBL] [Abstract][Full Text] [Related]
31. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?
To CH; Petri M
Arthritis Rheum; 2005 Dec; 52(12):4003-10. PubMed ID: 16320348
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
[TBL] [Abstract][Full Text] [Related]
33. Cigarette smoking and cutaneous damage in systemic lupus erythematosus.
Turchin I; Bernatsky S; Clarke AE; St-Pierre Y; Pineau CA
J Rheumatol; 2009 Dec; 36(12):2691-3. PubMed ID: 19884279
[TBL] [Abstract][Full Text] [Related]
34. Systemic lupus erythaematosus in a multiethnic US cohort (LUMINA) LIII: disease expression and outcome in acute onset lupus.
Bertoli AM; Vilá LM; Reveille JD; Alarcón GS;
Ann Rheum Dis; 2008 Apr; 67(4):500-4. PubMed ID: 17720721
[TBL] [Abstract][Full Text] [Related]
35. Menopause hormonal therapy in women with systemic lupus erythematosus.
Sánchez-Guerrero J; González-Pérez M; Durand-Carbajal M; Lara-Reyes P; Jiménez-Santana L; Romero-Díaz J; Cravioto MD
Arthritis Rheum; 2007 Sep; 56(9):3070-9. PubMed ID: 17763408
[TBL] [Abstract][Full Text] [Related]
36. Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events.
Ho KT; Ahn CW; Alarcón GS; Baethge BA; Tan FK; Roseman J; Bastian HM; Fessler BJ; McGwin G; Vilá LM; Calvo-Alén J; Reveille JD
Rheumatology (Oxford); 2005 Oct; 44(10):1303-7. PubMed ID: 16030085
[TBL] [Abstract][Full Text] [Related]
37. SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study.
Laustrup H; Voss A; Green A; Junker P
Lupus; 2010 Mar; 19(3):239-46. PubMed ID: 19946037
[TBL] [Abstract][Full Text] [Related]
38. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
[TBL] [Abstract][Full Text] [Related]
39. Socioeconomic status and health in women with systemic lupus erythematosus.
Lotstein DS; Ward MM; Bush TM; Lambert RE; van Vollenhoven R; Neuwelt CM
J Rheumatol; 1998 Sep; 25(9):1720-9. PubMed ID: 9733452
[TBL] [Abstract][Full Text] [Related]
40. Initial and accrued damage as predictors of mortality in Brazilian patients with systemic lupus erythematosus: a cohort study.
Cardoso CR; Signorelli FV; Papi JA; Salles GF
Lupus; 2008 Nov; 17(11):1042-8. PubMed ID: 18852231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
